MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients

Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is...

Descripción completa

Detalles Bibliográficos
Autores principales: Serana, Federico, Imberti, Luisa, Amato, Maria Pia, Comi, Giancarlo, Gasperini, Claudio, Ghezzi, Angelo, Martinelli, Vittorio, Provinciali, Leandro, Rottoli, Maria Rosa, Sotgiu, Stefano, Stecchi, Sergio, Vecchio, Michele, Zaffaroni, Mauro, Cordioli, Cinzia, Capra, Ruggero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986392/
https://www.ncbi.nlm.nih.gov/pubmed/24733382
http://dx.doi.org/10.1371/journal.pone.0094794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986392/
https://www.ncbi.nlm.nih.gov/pubmed/24733382
http://dx.doi.org/10.1371/journal.pone.0094794

Ejemplares similares